Published in J Clin Microbiol on February 01, 2000
Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J Clin Microbiol (2003) 1.62
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States. Appl Environ Microbiol (2005) 1.15
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol (2001) 1.10
Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol (2001) 1.07
Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis (2002) 0.97
In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis. J Clin Pathol (2004) 0.89
Reinfection with Anaplasma phagocytophilum in BALB/c mice and cross-protection between two sympatric isolates. Infect Immun (2004) 0.86
Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease. J Clin Microbiol (2013) 0.82
Persistence of granulocytic Ehrlichia infection during wintertime in two sheep flocks in Norway. Acta Vet Scand (2001) 0.80
Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization. J Clin Microbiol (2013) 0.80
Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol (2001) 0.78
Cloning of the major outer membrane protein expression locus in Anaplasma platys and seroreactivity of a species-specific antigen. J Bacteriol (2011) 0.76
Retrospective Study Investigating the Seroprevalence of Anaplasma phagocytophilum in Manitoba, Canada: 2011-2014. Open Forum Infect Dis (2016) 0.75
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26
Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA (1996) 4.88
Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia. J Clin Microbiol (1995) 4.54
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69
Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med (1998) 2.61
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98
Human granulocytic ehrlichiosis in Massachusetts. Ann Intern Med (1995) 1.81
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med (1998) 1.60
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol (1998) 1.30
Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis (1998) 1.19
Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J Clin Microbiol (1998) 1.17
Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. J Infect Dis (1998) 1.06
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol (1994) 9.97
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74
SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell (1993) 6.95
Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med (2001) 6.76
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res (2000) 5.88
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26
Global histone acetylation and deacetylation in yeast. Nature (2000) 5.16
A 300 kilobase interval genetic map of rice including 883 expressed sequences. Nat Genet (1994) 5.08
Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA (1996) 4.88
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature (1998) 4.86
SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci U S A (1993) 4.61
Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study. BMJ (1998) 4.52
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev (2001) 4.47
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30
Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol Cell (2001) 4.06
Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol (1994) 4.06
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med (2012) 3.88
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity (2000) 3.84
Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ (2006) 3.77
Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol (1994) 3.66
SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol (1998) 3.65
Cys-scanning mutagenesis: a novel approach to structure function relationships in polytopic membrane proteins. FASEB J (1998) 3.41
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41
Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6. Biochim Biophys Acta (1991) 3.39
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol (1997) 3.28
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proc Natl Acad Sci U S A (1996) 3.07
Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract (2001) 3.06
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02
Rice gibberellin-insensitive dwarf mutant gene Dwarf 1 encodes the alpha-subunit of GTP-binding protein. Proc Natl Acad Sci U S A (1999) 2.97
Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol (1995) 2.97
Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics (1995) 2.94
The Myxococcus xanthus pilT locus is required for social gliding motility although pili are still produced. Mol Microbiol (1997) 2.91
Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg (1989) 2.79
Impact of color blindness on recognition of blood in body fluids. Arch Intern Med (2001) 2.78
MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J (1992) 2.71
Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol Cell Biol (2000) 2.69
Serodiagnosis in early Lyme disease. J Clin Microbiol (1993) 2.69
Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J (1993) 2.66
OpenPET: A Flexible Electronics System for Radiotracer Imaging. IEEE Trans Nucl Sci (2009) 2.64
Infection due to Leuconostoc species: six cases and review. Rev Infect Dis (1990) 2.58
Lyme borreliosis. Lancet (1998) 2.57
Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity (1998) 2.54
Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res (1999) 2.47
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta (2004) 2.43
Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40
Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol (1995) 2.38
Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35
Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol (1997) 2.35
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis (1995) 2.31
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A (1997) 2.30
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med (Berl) (2005) 2.29
Smooth muscle and skeletal muscle myosins produce similar unitary forces and displacements in the laser trap. Biophys J (1997) 2.28
Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol (2000) 2.27
Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis (1997) 2.26
Human granulocytic ehrlichiosis in Europe. Lancet (1995) 2.25
Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J Virol (1996) 2.22
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature (1993) 2.14
Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol (1996) 2.14
StuA is required for cell pattern formation in Aspergillus. Genes Dev (1992) 2.14
Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg (1994) 2.13
PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol (1998) 2.12
Myosin conformational states determined by single fluorophore polarization. Proc Natl Acad Sci U S A (1998) 2.07
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol (1998) 2.06
A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem (1994) 2.06
The relationship of respiratory and cardiovascular hospital admissions to the southern California wildfires of 2003. Occup Environ Med (2008) 2.06
PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int (2006) 2.05
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med (1985) 1.99
Intrinsic fluorescence spectroscopy in turbid media: disentangling effects of scattering and absorption. Appl Opt (2001) 1.98
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98